Legal Representation
Attorney
Julie Tolek
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 8, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Nov 8, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Nov 8, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 21, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 21, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 21, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 27, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 6, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jun 6, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 6, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 6, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Nov 26, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 10, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and drug development using artificial intelligence; pharmaceutical research and drug development of biological macromolecules and multi-specific molecules; conducting early evaluations in the field of new pharmaceutical drugs using artificial intelligence; computer software design for pharmaceutical research and drug development using artificial intelligence; development of computer platforms for pharmaceutical research and drug development using artificial intelligence; research in the field of artificial intelligence technology for pharmaceutical drug development
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
NEO DEGRADER
Classification
International Classes
042